暗記メーカー

暗記メーカー

​
ログイン

LMR 10

LMR 10
100問 • 1年前
  • Yves Laure Pimentel
    • 通報

    問題一覧

  • 1

    NON-OPERCULATED AND MATURE (embryonated) when laid:

    SCHISTOSOMA eggs

  • 2

    OPERCULATED AND MATURE (embryonated) when laid:

    HETEROPHYES, OPISTORCHIS and CLONORCHIS eggs

  • 3

    egg CANNOT be differentiated under an ordinary light microscope.

    Clonorchis, Opistorchis and Heterophyid

  • 4

    OPERCULATED AND IMMATURE (unembryonated) when laid:

    FASCIOLA, FASCIOLOPSIS, PARAGONIMUS and ECHINOSTOMA eggs

  • 5

    Amoebic LIVER abscess (ALA) is the most common extra-intestinal form of

    amoebiasis

  • 6

    is the most common extra-intestinal form of amoebiasis

    Amoebic LIVER abscess (ALA)

  • 7

    ?: consistently UNINUCLEATED (1 NUCLEUS)

    Entamoeba polecki cyst

  • 8

    ACHROMATIC karyosomal granules:

    IODAMOEBA BUTSCHLII

  • 9

    ?karyosomal granules: IODAMOEBA BUTSCHLII

    ACHROMATIC

  • 10

    Amoeboflagellate:

    NAEGLERIA

  • 11

    Granulomatous amoebic meningoencephalitis:

    ACANTHAMOEBA

  • 12

    Gay bowel syndrome:

    G. LAMBLIA

  • 13

    Entero-string/String test:

    G. LAMBLIA

  • 14

    G. LAMBLIA test

    Entero-string/String

  • 15

    K39 and FAST (Fast Agglutination Screening Test) for

    Leishmania

  • 16

    Test for Leishmania

    K39 and FAST (Fast Agglutination Screening Test)

  • 17

    Rupture of RBCs every 72 hours:

    P. MALARIAE

  • 18

    Rupture of RBCs every ? hours: P. MALARIAE

    72

  • 19

    Band trophozoite:

    P. MALARIAE

  • 20

    Amoeboid trophozoite: PLASMODIUM SPP

    P. VIVAX

  • 21

    Crescent-shaped gametocytes:

    P. FALCIPARUM

  • 22

    : cyanobacterium-like body (CLB)

    Cyclospora cayetanensis

  • 23

    Circumoval Precipitin Test (COPT)

    SCHISTOSOMES

  • 24

    Test (?) SCHISTOSOMES

    Circumoval Precipitin Test COPT

  • 25

    Sabin Feldman Dye test:

    TOXOPLASMA

  • 26

    test: TOXOPLASMA

    Sabin Feldman Dye

  • 27

    Sheather sugar flotation technique:

    CRYPTOSPORIDIUM

  • 28

    technique: CRYPTOSPORIDIUM

    Sheather sugar flotation

  • 29

    Stool preservatives:

    formalin, Schaudinn’s solution, PVA (polyvinyl alcohol), MIF (merthiolateiodine-formalin) and SAF (sodium acetate-acetic acid formalin)

  • 30

    stain is mainly useful in demonstrating the detailed structures of MICROFILARIAE.

    . DELAFIELD HEMATOXYLIN

  • 31

    DELAFIELD HEMATOXYLIN stain is mainly useful in demonstrating the detailed structures of .

    MICROFILARIAE

  • 32

    Iron conversion factor from conventional to SI (µmol/L):

    0.179

  • 33

    conversion factor from conventional to SI (µmol/L): 0.179

    Iron

  • 34

    Bilirubin conversion factor from conventional to SI (µmol/L):

    17.1

  • 35

    conversion factor from conventional to SI (µmol/L): 17.1

    Bilirubin

  • 36

    Thyroxine conversion factor to SI (µg/dl to mmol/L):

    12.9

  • 37

    conversion factor to SI (µg/dl to mmol/L): 12.9

    Thyroxine

  • 38

    Specimen collection & processing:

    Pre-analytical QA

  • 39

    Long term accuracy of analytical methods:

    External QC

  • 40

    Abrupt change:

    Shift

  • 41

    Gradual change:

    Trend

  • 42

    One control value exceeds +2s and another exceeds -2s:

    R4s

  • 43

    2 consecutive ctrl values exceed the same mean +2s or -2s:

    2:2s

  • 44

    advantages over the horizontal centrifuge: Lesser air friction, smaller increase in sample temperature, quicker sedimentation of small particles, and operated over higher speed

    Fixed-angle centrifuge

  • 45

    Used to determine whether there is statistically significant difference between the SD of 2 groups of data:

    f-test

  • 46

    Used to determine whether there is statistically significant difference between the means of 2 groups of data:

    t-test

  • 47

    Sample of known quantity with several analytes.:

    Control

  • 48

    Anticoagulant for cardiopulmonary bypass:

    Heparin

  • 49

    Basal state collection: ? blood collection

    Early morning

  • 50

    ? collection: Early morning blood collection

    Basal state

  • 51

    . Uses 2 monochromators, affected by quenching:

    Fluorometry

  • 52

    . Uses ?, affected by quenching: Fluorometry

    2 monochromators

  • 53

    Uses 2 photodetectors, for the sample beam and reference beam:

    Double – beam in space

  • 54

    Uses ?, for the sample beam and reference beam: Double – beam in space

    2 photodetectors

  • 55

    Obsolete blood glucose methodologies:

    Folin- Wu, Nelson Somogyi

  • 56

    Chemical method for glucose, still widely used:

    Ortho-toluidine, condensation method

  • 57

    Test for chylomicrons, creamy layer on top:

    Standing plasma test

  • 58

    Apolipoprotein component of VLDL:

    Apo-B100

  • 59

    Transports exogenous triglycerides:

    Chylomicrons

  • 60

    Transports endogenous triglycerides:

    VLDL

  • 61

    Highest cholesterol content:

    LDL

  • 62

    One step method for cholesterol determination:

    Liebermann - Burchardt

  • 63

    : Used in enzymatic method of cholesterol determination

    Cholesterol esterase

  • 64

    CV of HDLc (NCEP Guidelines for Acceptable Measurement Error):?%

    ≤ 4%

  • 65

    Assay for Uric acid that uses mercury arc vapor lamp:

    Enzymatic: UV

  • 66

    Greater specificity and more expensive BUN assay: Enzymatic:

    ammonia formation

  • 67

    Simple, Nonspecific test for Creatinine determination :

    Colorimetric: end point

  • 68

    Categories of Azotemia:

    Pre-renal, Renal, Post-renal

  • 69

    Test used to assess the ability to conjugate bilirubin and secrete bile:

    Total and Direct Bilirubin assay

  • 70

    Gamma spike/ Monoclonal gammopathy:

    Multiple myeloma

  • 71

    ? spike/ Monoclonal gammopathy: Multiple myeloma

    Gamma

  • 72

    Gamma spike/ ?: Multiple myeloma

    Monoclonal gammopathy

  • 73

    Beta-gamma bridging:

    Hepatic cirrhosis

  • 74

    : Hepatic cirrhosis

    Beta-gamma bridging

  • 75

    Reaction rate is directly proportional to substrate concentration:

    First-order kinetics

  • 76

    Enzyme specific for both pancreas and salivary glands:

    Amylase

  • 77

    Clinically significant if decreased:

    Cholinesterase

  • 78

    Substrate used in Bowers-McComb method for ALP activity measurement:

    pnitrophenylphosphate

  • 79

    Substrate used in ? method for ALP activity measurement: pnitrophenylphosphate

    Bowers-McComb

  • 80

    Substrate used in Bowers-McComb method for ? activity measurement: pnitrophenylphosphate

    ALP

  • 81

    Chief counterion of sodium:

    Chloride

  • 82

    Driving force of bicarbonate buffer system:

    CARBON DIOXIDE

  • 83

    Chloride and Bicarbonate relationship:

    Reciprocal

  • 84

    Confirmatory test for Acromegaly:

    Glucose suppression test

  • 85

    Confirmatory test for ?: Glucose suppression test

    Acromegaly

  • 86

    Increased in Hypothyroidism (primary):

    TSH

  • 87

    Increased in ? (primary): TSH

    Hypothyroidism

  • 88

    T3 uptake levels in Hypothyroidism :

    Decreased

  • 89

    Begins with patient identification and continues until testing is completed and the results are reported :

    Chain of custody

  • 90

    Requires whole blood EDTA sample:

    Cyclosporine and Tacrolimus tests

  • 91

    Method of choice for measuring antidepressants:

    HPLC

  • 92

    Gold standard for drug testing:

    GC-MS

  • 93

    Inhibits acetylcholinesterase:

    Organophosphates & Carbamates

  • 94

    Inhibits ?: Organophosphates & Carbamates

    acetylcholinesterase

  • 95

    Dissociable substance that yields hydrogen ions:

    Acid

  • 96

    Dissociable substance that yields hydroxyl ions:

    Base

  • 97

    Dissociable substance that accepts hydroxyl ions:

    Acid

  • 98

    Comparing patient’s results with previous results:

    Delta check

  • 99

    is most often performed by nurses, perfusionists (who operate heart-lung machine during open heart surgery), respiratory therapists and physician themselves.

    POCT

  • 100

    Expressed in Ehrlich units (mg/dl):

    Urobilinogen

    • other names parasitology

    other names parasitology

    Yves Laure Pimentel · 70問 · 2年前

    other names parasitology

    other names parasitology

    70問 • 2年前
    Yves Laure Pimentel

    PARASITOLOGY

    PARASITOLOGY

    Yves Laure Pimentel · 111問 · 2年前

    PARASITOLOGY

    PARASITOLOGY

    111問 • 2年前
    Yves Laure Pimentel

    HTMLBE

    HTMLBE

    Yves Laure Pimentel · 64問 · 2年前

    HTMLBE

    HTMLBE

    64問 • 2年前
    Yves Laure Pimentel

    CC - 1 LAB. SAFETY, BASIC UNITS, AND CONVERSION FACTOR

    CC - 1 LAB. SAFETY, BASIC UNITS, AND CONVERSION FACTOR

    Yves Laure Pimentel · 61問 · 2年前

    CC - 1 LAB. SAFETY, BASIC UNITS, AND CONVERSION FACTOR

    CC - 1 LAB. SAFETY, BASIC UNITS, AND CONVERSION FACTOR

    61問 • 2年前
    Yves Laure Pimentel

    HISTOPATHOLOGY

    HISTOPATHOLOGY

    Yves Laure Pimentel · 69問 · 2年前

    HISTOPATHOLOGY

    HISTOPATHOLOGY

    69問 • 2年前
    Yves Laure Pimentel

    CC-2 SPECTROPHOTOMETRY

    CC-2 SPECTROPHOTOMETRY

    Yves Laure Pimentel · 100問 · 2年前

    CC-2 SPECTROPHOTOMETRY

    CC-2 SPECTROPHOTOMETRY

    100問 • 2年前
    Yves Laure Pimentel

    CC-3 ELECTROPHORESIS

    CC-3 ELECTROPHORESIS

    Yves Laure Pimentel · 41問 · 2年前

    CC-3 ELECTROPHORESIS

    CC-3 ELECTROPHORESIS

    41問 • 2年前
    Yves Laure Pimentel

    AUBF LAB SAFETY

    AUBF LAB SAFETY

    Yves Laure Pimentel · 87問 · 2年前

    AUBF LAB SAFETY

    AUBF LAB SAFETY

    87問 • 2年前
    Yves Laure Pimentel

    CSF 1

    CSF 1

    Yves Laure Pimentel · 100問 · 2年前

    CSF 1

    CSF 1

    100問 • 2年前
    Yves Laure Pimentel

    CSF 2

    CSF 2

    Yves Laure Pimentel · 82問 · 2年前

    CSF 2

    CSF 2

    82問 • 2年前
    Yves Laure Pimentel

    SEMEN 1

    SEMEN 1

    Yves Laure Pimentel · 100問 · 2年前

    SEMEN 1

    SEMEN 1

    100問 • 2年前
    Yves Laure Pimentel

    SEMEN 2

    SEMEN 2

    Yves Laure Pimentel · 7問 · 2年前

    SEMEN 2

    SEMEN 2

    7問 • 2年前
    Yves Laure Pimentel

    SYNOVIAL FLUID 1

    SYNOVIAL FLUID 1

    Yves Laure Pimentel · 100問 · 2年前

    SYNOVIAL FLUID 1

    SYNOVIAL FLUID 1

    100問 • 2年前
    Yves Laure Pimentel

    SYNOVIAL FLUID 2

    SYNOVIAL FLUID 2

    Yves Laure Pimentel · 6問 · 2年前

    SYNOVIAL FLUID 2

    SYNOVIAL FLUID 2

    6問 • 2年前
    Yves Laure Pimentel

    SEROUS FLUID

    SEROUS FLUID

    Yves Laure Pimentel · 25問 · 2年前

    SEROUS FLUID

    SEROUS FLUID

    25問 • 2年前
    Yves Laure Pimentel

    PLEURAL FLUID

    PLEURAL FLUID

    Yves Laure Pimentel · 44問 · 2年前

    PLEURAL FLUID

    PLEURAL FLUID

    44問 • 2年前
    Yves Laure Pimentel

    PERICARDIAL FLUID

    PERICARDIAL FLUID

    Yves Laure Pimentel · 18問 · 2年前

    PERICARDIAL FLUID

    PERICARDIAL FLUID

    18問 • 2年前
    Yves Laure Pimentel

    PERITONEAL FLUID/ ASCITIC FLUID

    PERITONEAL FLUID/ ASCITIC FLUID

    Yves Laure Pimentel · 30問 · 2年前

    PERITONEAL FLUID/ ASCITIC FLUID

    PERITONEAL FLUID/ ASCITIC FLUID

    30問 • 2年前
    Yves Laure Pimentel

    AMNIOTIC FLUID

    AMNIOTIC FLUID

    Yves Laure Pimentel · 92問 · 2年前

    AMNIOTIC FLUID

    AMNIOTIC FLUID

    92問 • 2年前
    Yves Laure Pimentel

    FECALYSIS

    FECALYSIS

    Yves Laure Pimentel · 80問 · 2年前

    FECALYSIS

    FECALYSIS

    80問 • 2年前
    Yves Laure Pimentel

    OTHER BODY FLUIDS

    OTHER BODY FLUIDS

    Yves Laure Pimentel · 89問 · 2年前

    OTHER BODY FLUIDS

    OTHER BODY FLUIDS

    89問 • 2年前
    Yves Laure Pimentel

    MTLBE- SUHO NOTES

    MTLBE- SUHO NOTES

    Yves Laure Pimentel · 86問 · 2年前

    MTLBE- SUHO NOTES

    MTLBE- SUHO NOTES

    86問 • 2年前
    Yves Laure Pimentel

    MTLBE..

    MTLBE..

    Yves Laure Pimentel · 35問 · 2年前

    MTLBE..

    MTLBE..

    35問 • 2年前
    Yves Laure Pimentel

    CC- CHROMATOGRAPHY

    CC- CHROMATOGRAPHY

    Yves Laure Pimentel · 19問 · 1年前

    CC- CHROMATOGRAPHY

    CC- CHROMATOGRAPHY

    19問 • 1年前
    Yves Laure Pimentel

    CC-OSMOMETRY

    CC-OSMOMETRY

    Yves Laure Pimentel · 14問 · 1年前

    CC-OSMOMETRY

    CC-OSMOMETRY

    14問 • 1年前
    Yves Laure Pimentel

    CC-ELECTROCHEMISTRY TECHNIQUES

    CC-ELECTROCHEMISTRY TECHNIQUES

    Yves Laure Pimentel · 43問 · 1年前

    CC-ELECTROCHEMISTRY TECHNIQUES

    CC-ELECTROCHEMISTRY TECHNIQUES

    43問 • 1年前
    Yves Laure Pimentel

    CC- CARBOHYDRATES

    CC- CARBOHYDRATES

    Yves Laure Pimentel · 49問 · 2年前

    CC- CARBOHYDRATES

    CC- CARBOHYDRATES

    49問 • 2年前
    Yves Laure Pimentel

    CC- DIABETES MELLITUS

    CC- DIABETES MELLITUS

    Yves Laure Pimentel · 97問 · 2年前

    CC- DIABETES MELLITUS

    CC- DIABETES MELLITUS

    97問 • 2年前
    Yves Laure Pimentel

    MAJOR LIPOPROTEINS

    MAJOR LIPOPROTEINS

    Yves Laure Pimentel · 57問 · 2年前

    MAJOR LIPOPROTEINS

    MAJOR LIPOPROTEINS

    57問 • 2年前
    Yves Laure Pimentel

    MINOR LIPOPROTEINS

    MINOR LIPOPROTEINS

    Yves Laure Pimentel · 63問 · 2年前

    MINOR LIPOPROTEINS

    MINOR LIPOPROTEINS

    63問 • 2年前
    Yves Laure Pimentel

    PROTEINS

    PROTEINS

    Yves Laure Pimentel · 37問 · 2年前

    PROTEINS

    PROTEINS

    37問 • 2年前
    Yves Laure Pimentel

    PLASMA PROTEINS 1

    PLASMA PROTEINS 1

    Yves Laure Pimentel · 91問 · 2年前

    PLASMA PROTEINS 1

    PLASMA PROTEINS 1

    91問 • 2年前
    Yves Laure Pimentel

    PLASMA PROTEINS 2 (ALPHA 2 REGION)

    PLASMA PROTEINS 2 (ALPHA 2 REGION)

    Yves Laure Pimentel · 98問 · 2年前

    PLASMA PROTEINS 2 (ALPHA 2 REGION)

    PLASMA PROTEINS 2 (ALPHA 2 REGION)

    98問 • 2年前
    Yves Laure Pimentel

    MISCELLANEOUS PROTEINS

    MISCELLANEOUS PROTEINS

    Yves Laure Pimentel · 61問 · 2年前

    MISCELLANEOUS PROTEINS

    MISCELLANEOUS PROTEINS

    61問 • 2年前
    Yves Laure Pimentel

    Liver Function Test 1

    Liver Function Test 1

    Yves Laure Pimentel · 100問 · 2年前

    Liver Function Test 1

    Liver Function Test 1

    100問 • 2年前
    Yves Laure Pimentel

    Liver Function Test 2

    Liver Function Test 2

    Yves Laure Pimentel · 96問 · 2年前

    Liver Function Test 2

    Liver Function Test 2

    96問 • 2年前
    Yves Laure Pimentel

    TUMOR MARKERS

    TUMOR MARKERS

    Yves Laure Pimentel · 33問 · 2年前

    TUMOR MARKERS

    TUMOR MARKERS

    33問 • 2年前
    Yves Laure Pimentel

    KIDNEY FUNCTION TESTS - NON PROTEIN NITROGEN & CREATININE

    KIDNEY FUNCTION TESTS - NON PROTEIN NITROGEN & CREATININE

    Yves Laure Pimentel · 41問 · 2年前

    KIDNEY FUNCTION TESTS - NON PROTEIN NITROGEN & CREATININE

    KIDNEY FUNCTION TESTS - NON PROTEIN NITROGEN & CREATININE

    41問 • 2年前
    Yves Laure Pimentel

    GLYCOGEN STORAGE DISEASES

    GLYCOGEN STORAGE DISEASES

    Yves Laure Pimentel · 17問 · 2年前

    GLYCOGEN STORAGE DISEASES

    GLYCOGEN STORAGE DISEASES

    17問 • 2年前
    Yves Laure Pimentel

    LIPID STORAGE DISEASES

    LIPID STORAGE DISEASES

    Yves Laure Pimentel · 14問 · 2年前

    LIPID STORAGE DISEASES

    LIPID STORAGE DISEASES

    14問 • 2年前
    Yves Laure Pimentel

    PROTEINS

    PROTEINS

    Yves Laure Pimentel · 71問 · 2年前

    PROTEINS

    PROTEINS

    71問 • 2年前
    Yves Laure Pimentel

    QUICK FIRE- ELECTRODES

    QUICK FIRE- ELECTRODES

    Yves Laure Pimentel · 7問 · 2年前

    QUICK FIRE- ELECTRODES

    QUICK FIRE- ELECTRODES

    7問 • 2年前
    Yves Laure Pimentel

    ELECTROLYTES

    ELECTROLYTES

    Yves Laure Pimentel · 10問 · 2年前

    ELECTROLYTES

    ELECTROLYTES

    10問 • 2年前
    Yves Laure Pimentel

    DRUGS

    DRUGS

    Yves Laure Pimentel · 27問 · 2年前

    DRUGS

    DRUGS

    27問 • 2年前
    Yves Laure Pimentel

    TOXIC AGENTS:

    TOXIC AGENTS:

    Yves Laure Pimentel · 12問 · 2年前

    TOXIC AGENTS:

    TOXIC AGENTS:

    12問 • 2年前
    Yves Laure Pimentel

    HEMATOLOGY 1 (HEMATOPOIESIS 1)

    HEMATOLOGY 1 (HEMATOPOIESIS 1)

    Yves Laure Pimentel · 100問 · 2年前

    HEMATOLOGY 1 (HEMATOPOIESIS 1)

    HEMATOLOGY 1 (HEMATOPOIESIS 1)

    100問 • 2年前
    Yves Laure Pimentel

    HEMATOLOGY (HEMATOPOIESIS 2)

    HEMATOLOGY (HEMATOPOIESIS 2)

    Yves Laure Pimentel · 29問 · 2年前

    HEMATOLOGY (HEMATOPOIESIS 2)

    HEMATOLOGY (HEMATOPOIESIS 2)

    29問 • 2年前
    Yves Laure Pimentel

    hema diseases

    hema diseases

    Yves Laure Pimentel · 25問 · 2年前

    hema diseases

    hema diseases

    25問 • 2年前
    Yves Laure Pimentel

    AML

    AML

    Yves Laure Pimentel · 43問 · 2年前

    AML

    AML

    43問 • 2年前
    Yves Laure Pimentel

    GLOBIN SYNTHESIS

    GLOBIN SYNTHESIS

    Yves Laure Pimentel · 71問 · 2年前

    GLOBIN SYNTHESIS

    GLOBIN SYNTHESIS

    71問 • 2年前
    Yves Laure Pimentel

    HEMATOLOGY REFERENCE RANGES

    HEMATOLOGY REFERENCE RANGES

    Yves Laure Pimentel · 31問 · 2年前

    HEMATOLOGY REFERENCE RANGES

    HEMATOLOGY REFERENCE RANGES

    31問 • 2年前
    Yves Laure Pimentel

    DISORDERS OF PRIMARY HEMOSTASIS

    DISORDERS OF PRIMARY HEMOSTASIS

    Yves Laure Pimentel · 34問 · 2年前

    DISORDERS OF PRIMARY HEMOSTASIS

    DISORDERS OF PRIMARY HEMOSTASIS

    34問 • 2年前
    Yves Laure Pimentel

    PLATELET DISORDERS

    PLATELET DISORDERS

    Yves Laure Pimentel · 37問 · 2年前

    PLATELET DISORDERS

    PLATELET DISORDERS

    37問 • 2年前
    Yves Laure Pimentel

    CHARACTERISTICS OF CLOTTING FACTORS

    CHARACTERISTICS OF CLOTTING FACTORS

    Yves Laure Pimentel · 100問 · 2年前

    CHARACTERISTICS OF CLOTTING FACTORS

    CHARACTERISTICS OF CLOTTING FACTORS

    100問 • 2年前
    Yves Laure Pimentel

    4. CLASSIFICATION OF MACROPHAGE

    4. CLASSIFICATION OF MACROPHAGE

    Yves Laure Pimentel · 12問 · 2年前

    4. CLASSIFICATION OF MACROPHAGE

    4. CLASSIFICATION OF MACROPHAGE

    12問 • 2年前
    Yves Laure Pimentel

    3. NATURAL OR INNATE IMMUNITY

    3. NATURAL OR INNATE IMMUNITY

    Yves Laure Pimentel · 39問 · 2年前

    3. NATURAL OR INNATE IMMUNITY

    3. NATURAL OR INNATE IMMUNITY

    39問 • 2年前
    Yves Laure Pimentel

    5. INTERNAL DEFENSE:SOLUBLE FACTORS (ACUTE PHASE REACTANTS)

    5. INTERNAL DEFENSE:SOLUBLE FACTORS (ACUTE PHASE REACTANTS)

    Yves Laure Pimentel · 55問 · 2年前

    5. INTERNAL DEFENSE:SOLUBLE FACTORS (ACUTE PHASE REACTANTS)

    5. INTERNAL DEFENSE:SOLUBLE FACTORS (ACUTE PHASE REACTANTS)

    55問 • 2年前
    Yves Laure Pimentel

    6. PHAGOCYTOSIS Chemotaxis

    6. PHAGOCYTOSIS Chemotaxis

    Yves Laure Pimentel · 37問 · 2年前

    6. PHAGOCYTOSIS Chemotaxis

    6. PHAGOCYTOSIS Chemotaxis

    37問 • 2年前
    Yves Laure Pimentel

    8. NATURE OF ANTIGEN

    8. NATURE OF ANTIGEN

    Yves Laure Pimentel · 44問 · 2年前

    8. NATURE OF ANTIGEN

    8. NATURE OF ANTIGEN

    44問 • 2年前
    Yves Laure Pimentel

    9. MAJOR HISTOCOMPATIBILITY COMPLEX/HUMAN LEUKOCYTE ANTIGEN

    9. MAJOR HISTOCOMPATIBILITY COMPLEX/HUMAN LEUKOCYTE ANTIGEN

    Yves Laure Pimentel · 50問 · 2年前

    9. MAJOR HISTOCOMPATIBILITY COMPLEX/HUMAN LEUKOCYTE ANTIGEN

    9. MAJOR HISTOCOMPATIBILITY COMPLEX/HUMAN LEUKOCYTE ANTIGEN

    50問 • 2年前
    Yves Laure Pimentel

    1. HISTORY

    1. HISTORY

    Yves Laure Pimentel · 69問 · 2年前

    1. HISTORY

    1. HISTORY

    69問 • 2年前
    Yves Laure Pimentel

    2. TYPES OF IMMUNITY

    2. TYPES OF IMMUNITY

    Yves Laure Pimentel · 38問 · 2年前

    2. TYPES OF IMMUNITY

    2. TYPES OF IMMUNITY

    38問 • 2年前
    Yves Laure Pimentel

    7. PHAGOCYTOSIS Engulfment and Digestion

    7. PHAGOCYTOSIS Engulfment and Digestion

    Yves Laure Pimentel · 21問 · 2年前

    7. PHAGOCYTOSIS Engulfment and Digestion

    7. PHAGOCYTOSIS Engulfment and Digestion

    21問 • 2年前
    Yves Laure Pimentel

    8. PHAGOCYTOSIS EXOCYTOSIS

    8. PHAGOCYTOSIS EXOCYTOSIS

    Yves Laure Pimentel · 15問 · 2年前

    8. PHAGOCYTOSIS EXOCYTOSIS

    8. PHAGOCYTOSIS EXOCYTOSIS

    15問 • 2年前
    Yves Laure Pimentel

    10. DISEASE ASSOCIATED TO HUMAN LEUKOCYTE ANTIGEN (henry)

    10. DISEASE ASSOCIATED TO HUMAN LEUKOCYTE ANTIGEN (henry)

    Yves Laure Pimentel · 32問 · 2年前

    10. DISEASE ASSOCIATED TO HUMAN LEUKOCYTE ANTIGEN (henry)

    10. DISEASE ASSOCIATED TO HUMAN LEUKOCYTE ANTIGEN (henry)

    32問 • 2年前
    Yves Laure Pimentel

    11. TRANSPLANTATION IMMUNOLOGY

    11. TRANSPLANTATION IMMUNOLOGY

    Yves Laure Pimentel · 30問 · 2年前

    11. TRANSPLANTATION IMMUNOLOGY

    11. TRANSPLANTATION IMMUNOLOGY

    30問 • 2年前
    Yves Laure Pimentel

    2. LYMPHOID ORGANS

    2. LYMPHOID ORGANS

    Yves Laure Pimentel · 38問 · 2年前

    2. LYMPHOID ORGANS

    2. LYMPHOID ORGANS

    38問 • 2年前
    Yves Laure Pimentel

    3. CLUSTER OF DIFFERENTIATION

    3. CLUSTER OF DIFFERENTIATION

    Yves Laure Pimentel · 48問 · 2年前

    3. CLUSTER OF DIFFERENTIATION

    3. CLUSTER OF DIFFERENTIATION

    48問 • 2年前
    Yves Laure Pimentel

    4. T-CELL DIFFERENTIATION

    4. T-CELL DIFFERENTIATION

    Yves Laure Pimentel · 35問 · 2年前

    4. T-CELL DIFFERENTIATION

    4. T-CELL DIFFERENTIATION

    35問 • 2年前
    Yves Laure Pimentel

    5. T CELL IMMUNODEFICIENCIES

    5. T CELL IMMUNODEFICIENCIES

    Yves Laure Pimentel · 18問 · 2年前

    5. T CELL IMMUNODEFICIENCIES

    5. T CELL IMMUNODEFICIENCIES

    18問 • 2年前
    Yves Laure Pimentel

    6. STAGES IN B-CELL DIFFERENTIATION  PROPIMAP

    6. STAGES IN B-CELL DIFFERENTIATION  PROPIMAP

    Yves Laure Pimentel · 44問 · 2年前

    6. STAGES IN B-CELL DIFFERENTIATION  PROPIMAP

    6. STAGES IN B-CELL DIFFERENTIATION  PROPIMAP

    44問 • 2年前
    Yves Laure Pimentel

    7. B CELL IMMUNODEFICIENCIES

    7. B CELL IMMUNODEFICIENCIES

    Yves Laure Pimentel · 23問 · 2年前

    7. B CELL IMMUNODEFICIENCIES

    7. B CELL IMMUNODEFICIENCIES

    23問 • 2年前
    Yves Laure Pimentel

    8. COMBINED T CELL AND B CELL DEFICIENCIES

    8. COMBINED T CELL AND B CELL DEFICIENCIES

    Yves Laure Pimentel · 34問 · 2年前

    8. COMBINED T CELL AND B CELL DEFICIENCIES

    8. COMBINED T CELL AND B CELL DEFICIENCIES

    34問 • 2年前
    Yves Laure Pimentel

    9. COMPARISON OF T AND B CELLS

    9. COMPARISON OF T AND B CELLS

    Yves Laure Pimentel · 12問 · 2年前

    9. COMPARISON OF T AND B CELLS

    9. COMPARISON OF T AND B CELLS

    12問 • 2年前
    Yves Laure Pimentel

    10. LABORATORY IDENTIFICATION OF LYMPHOCYTES

    10. LABORATORY IDENTIFICATION OF LYMPHOCYTES

    Yves Laure Pimentel · 16問 · 2年前

    10. LABORATORY IDENTIFICATION OF LYMPHOCYTES

    10. LABORATORY IDENTIFICATION OF LYMPHOCYTES

    16問 • 2年前
    Yves Laure Pimentel

    11. NATURAL KILLER CELLS OR THIRD POPULATION CELL

    11. NATURAL KILLER CELLS OR THIRD POPULATION CELL

    Yves Laure Pimentel · 15問 · 2年前

    11. NATURAL KILLER CELLS OR THIRD POPULATION CELL

    11. NATURAL KILLER CELLS OR THIRD POPULATION CELL

    15問 • 2年前
    Yves Laure Pimentel

    12. ANTIBODY

    12. ANTIBODY

    Yves Laure Pimentel · 79問 · 2年前

    12. ANTIBODY

    12. ANTIBODY

    79問 • 2年前
    Yves Laure Pimentel

    13. TYPES OF ANTIBODIES

    13. TYPES OF ANTIBODIES

    Yves Laure Pimentel · 97問 · 2年前

    13. TYPES OF ANTIBODIES

    13. TYPES OF ANTIBODIES

    97問 • 2年前
    Yves Laure Pimentel

    14. MONOCLONAL ANTIBODIES

    14. MONOCLONAL ANTIBODIES

    Yves Laure Pimentel · 11問 · 2年前

    14. MONOCLONAL ANTIBODIES

    14. MONOCLONAL ANTIBODIES

    11問 • 2年前
    Yves Laure Pimentel

    1. INTERLEUKINS

    1. INTERLEUKINS

    Yves Laure Pimentel · 23問 · 2年前

    1. INTERLEUKINS

    1. INTERLEUKINS

    23問 • 2年前
    Yves Laure Pimentel

    2. INTERFERONS

    2. INTERFERONS

    Yves Laure Pimentel · 28問 · 2年前

    2. INTERFERONS

    2. INTERFERONS

    28問 • 2年前
    Yves Laure Pimentel

    3. CYTOKINES IN THE INNATE AND ADAPTIVE IMMUNITY

    3. CYTOKINES IN THE INNATE AND ADAPTIVE IMMUNITY

    Yves Laure Pimentel · 8問 · 2年前

    3. CYTOKINES IN THE INNATE AND ADAPTIVE IMMUNITY

    3. CYTOKINES IN THE INNATE AND ADAPTIVE IMMUNITY

    8問 • 2年前
    Yves Laure Pimentel

    4. COMPLEMENT SYSTEM

    4. COMPLEMENT SYSTEM

    Yves Laure Pimentel · 19問 · 2年前

    4. COMPLEMENT SYSTEM

    4. COMPLEMENT SYSTEM

    19問 • 2年前
    Yves Laure Pimentel

    15. COMPLEMENT SYSTEM

    15. COMPLEMENT SYSTEM

    Yves Laure Pimentel · 76問 · 2年前

    15. COMPLEMENT SYSTEM

    15. COMPLEMENT SYSTEM

    76問 • 2年前
    Yves Laure Pimentel

    16. SYSTEM CONTROLS/COMPLEMENT REGULATION

    16. SYSTEM CONTROLS/COMPLEMENT REGULATION

    Yves Laure Pimentel · 21問 · 2年前

    16. SYSTEM CONTROLS/COMPLEMENT REGULATION

    16. SYSTEM CONTROLS/COMPLEMENT REGULATION

    21問 • 2年前
    Yves Laure Pimentel

    17. COMPLEMENT AND DISEASE STATES

    17. COMPLEMENT AND DISEASE STATES

    Yves Laure Pimentel · 29問 · 2年前

    17. COMPLEMENT AND DISEASE STATES

    17. COMPLEMENT AND DISEASE STATES

    29問 • 2年前
    Yves Laure Pimentel

    18. IMMUNOLOGIC ASSAYS OF INDIVIDUAL COMPONENTS (CLASSICAL)

    18. IMMUNOLOGIC ASSAYS OF INDIVIDUAL COMPONENTS (CLASSICAL)

    Yves Laure Pimentel · 19問 · 2年前

    18. IMMUNOLOGIC ASSAYS OF INDIVIDUAL COMPONENTS (CLASSICAL)

    18. IMMUNOLOGIC ASSAYS OF INDIVIDUAL COMPONENTS (CLASSICAL)

    19問 • 2年前
    Yves Laure Pimentel

    19. CYTOKINES

    19. CYTOKINES

    Yves Laure Pimentel · 22問 · 2年前

    19. CYTOKINES

    19. CYTOKINES

    22問 • 2年前
    Yves Laure Pimentel

    20. INTERLEUKINS

    20. INTERLEUKINS

    Yves Laure Pimentel · 24問 · 2年前

    20. INTERLEUKINS

    20. INTERLEUKINS

    24問 • 2年前
    Yves Laure Pimentel

    21. INTERFERONS, TNF, TGF, CHEMOKINE

    21. INTERFERONS, TNF, TGF, CHEMOKINE

    Yves Laure Pimentel · 21問 · 2年前

    21. INTERFERONS, TNF, TGF, CHEMOKINE

    21. INTERFERONS, TNF, TGF, CHEMOKINE

    21問 • 2年前
    Yves Laure Pimentel

    1. SERO

    1. SERO

    Yves Laure Pimentel · 54問 · 2年前

    1. SERO

    1. SERO

    54問 • 2年前
    Yves Laure Pimentel

    2. PRECIPITATION

    2. PRECIPITATION

    Yves Laure Pimentel · 38問 · 2年前

    2. PRECIPITATION

    2. PRECIPITATION

    38問 • 2年前
    Yves Laure Pimentel

    3. PASSIVE IMMUNODIFFUSION

    3. PASSIVE IMMUNODIFFUSION

    Yves Laure Pimentel · 17問 · 2年前

    3. PASSIVE IMMUNODIFFUSION

    3. PASSIVE IMMUNODIFFUSION

    17問 • 2年前
    Yves Laure Pimentel

    4. OUCHTERLONY

    4. OUCHTERLONY

    Yves Laure Pimentel · 15問 · 2年前

    4. OUCHTERLONY

    4. OUCHTERLONY

    15問 • 2年前
    Yves Laure Pimentel

    5. ELECTROPHORETIC TECHNIQUE

    5. ELECTROPHORETIC TECHNIQUE

    Yves Laure Pimentel · 9問 · 2年前

    5. ELECTROPHORETIC TECHNIQUE

    5. ELECTROPHORETIC TECHNIQUE

    9問 • 2年前
    Yves Laure Pimentel

    6. IMMUNOELECTROPHORESIS (DOUBLE DIFFUSION)

    6. IMMUNOELECTROPHORESIS (DOUBLE DIFFUSION)

    Yves Laure Pimentel · 11問 · 2年前

    6. IMMUNOELECTROPHORESIS (DOUBLE DIFFUSION)

    6. IMMUNOELECTROPHORESIS (DOUBLE DIFFUSION)

    11問 • 2年前
    Yves Laure Pimentel

    7. IMMUNOFIXATION ELECTROPHORESIS

    7. IMMUNOFIXATION ELECTROPHORESIS

    Yves Laure Pimentel · 29問 · 2年前

    7. IMMUNOFIXATION ELECTROPHORESIS

    7. IMMUNOFIXATION ELECTROPHORESIS

    29問 • 2年前
    Yves Laure Pimentel

    問題一覧

  • 1

    NON-OPERCULATED AND MATURE (embryonated) when laid:

    SCHISTOSOMA eggs

  • 2

    OPERCULATED AND MATURE (embryonated) when laid:

    HETEROPHYES, OPISTORCHIS and CLONORCHIS eggs

  • 3

    egg CANNOT be differentiated under an ordinary light microscope.

    Clonorchis, Opistorchis and Heterophyid

  • 4

    OPERCULATED AND IMMATURE (unembryonated) when laid:

    FASCIOLA, FASCIOLOPSIS, PARAGONIMUS and ECHINOSTOMA eggs

  • 5

    Amoebic LIVER abscess (ALA) is the most common extra-intestinal form of

    amoebiasis

  • 6

    is the most common extra-intestinal form of amoebiasis

    Amoebic LIVER abscess (ALA)

  • 7

    ?: consistently UNINUCLEATED (1 NUCLEUS)

    Entamoeba polecki cyst

  • 8

    ACHROMATIC karyosomal granules:

    IODAMOEBA BUTSCHLII

  • 9

    ?karyosomal granules: IODAMOEBA BUTSCHLII

    ACHROMATIC

  • 10

    Amoeboflagellate:

    NAEGLERIA

  • 11

    Granulomatous amoebic meningoencephalitis:

    ACANTHAMOEBA

  • 12

    Gay bowel syndrome:

    G. LAMBLIA

  • 13

    Entero-string/String test:

    G. LAMBLIA

  • 14

    G. LAMBLIA test

    Entero-string/String

  • 15

    K39 and FAST (Fast Agglutination Screening Test) for

    Leishmania

  • 16

    Test for Leishmania

    K39 and FAST (Fast Agglutination Screening Test)

  • 17

    Rupture of RBCs every 72 hours:

    P. MALARIAE

  • 18

    Rupture of RBCs every ? hours: P. MALARIAE

    72

  • 19

    Band trophozoite:

    P. MALARIAE

  • 20

    Amoeboid trophozoite: PLASMODIUM SPP

    P. VIVAX

  • 21

    Crescent-shaped gametocytes:

    P. FALCIPARUM

  • 22

    : cyanobacterium-like body (CLB)

    Cyclospora cayetanensis

  • 23

    Circumoval Precipitin Test (COPT)

    SCHISTOSOMES

  • 24

    Test (?) SCHISTOSOMES

    Circumoval Precipitin Test COPT

  • 25

    Sabin Feldman Dye test:

    TOXOPLASMA

  • 26

    test: TOXOPLASMA

    Sabin Feldman Dye

  • 27

    Sheather sugar flotation technique:

    CRYPTOSPORIDIUM

  • 28

    technique: CRYPTOSPORIDIUM

    Sheather sugar flotation

  • 29

    Stool preservatives:

    formalin, Schaudinn’s solution, PVA (polyvinyl alcohol), MIF (merthiolateiodine-formalin) and SAF (sodium acetate-acetic acid formalin)

  • 30

    stain is mainly useful in demonstrating the detailed structures of MICROFILARIAE.

    . DELAFIELD HEMATOXYLIN

  • 31

    DELAFIELD HEMATOXYLIN stain is mainly useful in demonstrating the detailed structures of .

    MICROFILARIAE

  • 32

    Iron conversion factor from conventional to SI (µmol/L):

    0.179

  • 33

    conversion factor from conventional to SI (µmol/L): 0.179

    Iron

  • 34

    Bilirubin conversion factor from conventional to SI (µmol/L):

    17.1

  • 35

    conversion factor from conventional to SI (µmol/L): 17.1

    Bilirubin

  • 36

    Thyroxine conversion factor to SI (µg/dl to mmol/L):

    12.9

  • 37

    conversion factor to SI (µg/dl to mmol/L): 12.9

    Thyroxine

  • 38

    Specimen collection & processing:

    Pre-analytical QA

  • 39

    Long term accuracy of analytical methods:

    External QC

  • 40

    Abrupt change:

    Shift

  • 41

    Gradual change:

    Trend

  • 42

    One control value exceeds +2s and another exceeds -2s:

    R4s

  • 43

    2 consecutive ctrl values exceed the same mean +2s or -2s:

    2:2s

  • 44

    advantages over the horizontal centrifuge: Lesser air friction, smaller increase in sample temperature, quicker sedimentation of small particles, and operated over higher speed

    Fixed-angle centrifuge

  • 45

    Used to determine whether there is statistically significant difference between the SD of 2 groups of data:

    f-test

  • 46

    Used to determine whether there is statistically significant difference between the means of 2 groups of data:

    t-test

  • 47

    Sample of known quantity with several analytes.:

    Control

  • 48

    Anticoagulant for cardiopulmonary bypass:

    Heparin

  • 49

    Basal state collection: ? blood collection

    Early morning

  • 50

    ? collection: Early morning blood collection

    Basal state

  • 51

    . Uses 2 monochromators, affected by quenching:

    Fluorometry

  • 52

    . Uses ?, affected by quenching: Fluorometry

    2 monochromators

  • 53

    Uses 2 photodetectors, for the sample beam and reference beam:

    Double – beam in space

  • 54

    Uses ?, for the sample beam and reference beam: Double – beam in space

    2 photodetectors

  • 55

    Obsolete blood glucose methodologies:

    Folin- Wu, Nelson Somogyi

  • 56

    Chemical method for glucose, still widely used:

    Ortho-toluidine, condensation method

  • 57

    Test for chylomicrons, creamy layer on top:

    Standing plasma test

  • 58

    Apolipoprotein component of VLDL:

    Apo-B100

  • 59

    Transports exogenous triglycerides:

    Chylomicrons

  • 60

    Transports endogenous triglycerides:

    VLDL

  • 61

    Highest cholesterol content:

    LDL

  • 62

    One step method for cholesterol determination:

    Liebermann - Burchardt

  • 63

    : Used in enzymatic method of cholesterol determination

    Cholesterol esterase

  • 64

    CV of HDLc (NCEP Guidelines for Acceptable Measurement Error):?%

    ≤ 4%

  • 65

    Assay for Uric acid that uses mercury arc vapor lamp:

    Enzymatic: UV

  • 66

    Greater specificity and more expensive BUN assay: Enzymatic:

    ammonia formation

  • 67

    Simple, Nonspecific test for Creatinine determination :

    Colorimetric: end point

  • 68

    Categories of Azotemia:

    Pre-renal, Renal, Post-renal

  • 69

    Test used to assess the ability to conjugate bilirubin and secrete bile:

    Total and Direct Bilirubin assay

  • 70

    Gamma spike/ Monoclonal gammopathy:

    Multiple myeloma

  • 71

    ? spike/ Monoclonal gammopathy: Multiple myeloma

    Gamma

  • 72

    Gamma spike/ ?: Multiple myeloma

    Monoclonal gammopathy

  • 73

    Beta-gamma bridging:

    Hepatic cirrhosis

  • 74

    : Hepatic cirrhosis

    Beta-gamma bridging

  • 75

    Reaction rate is directly proportional to substrate concentration:

    First-order kinetics

  • 76

    Enzyme specific for both pancreas and salivary glands:

    Amylase

  • 77

    Clinically significant if decreased:

    Cholinesterase

  • 78

    Substrate used in Bowers-McComb method for ALP activity measurement:

    pnitrophenylphosphate

  • 79

    Substrate used in ? method for ALP activity measurement: pnitrophenylphosphate

    Bowers-McComb

  • 80

    Substrate used in Bowers-McComb method for ? activity measurement: pnitrophenylphosphate

    ALP

  • 81

    Chief counterion of sodium:

    Chloride

  • 82

    Driving force of bicarbonate buffer system:

    CARBON DIOXIDE

  • 83

    Chloride and Bicarbonate relationship:

    Reciprocal

  • 84

    Confirmatory test for Acromegaly:

    Glucose suppression test

  • 85

    Confirmatory test for ?: Glucose suppression test

    Acromegaly

  • 86

    Increased in Hypothyroidism (primary):

    TSH

  • 87

    Increased in ? (primary): TSH

    Hypothyroidism

  • 88

    T3 uptake levels in Hypothyroidism :

    Decreased

  • 89

    Begins with patient identification and continues until testing is completed and the results are reported :

    Chain of custody

  • 90

    Requires whole blood EDTA sample:

    Cyclosporine and Tacrolimus tests

  • 91

    Method of choice for measuring antidepressants:

    HPLC

  • 92

    Gold standard for drug testing:

    GC-MS

  • 93

    Inhibits acetylcholinesterase:

    Organophosphates & Carbamates

  • 94

    Inhibits ?: Organophosphates & Carbamates

    acetylcholinesterase

  • 95

    Dissociable substance that yields hydrogen ions:

    Acid

  • 96

    Dissociable substance that yields hydroxyl ions:

    Base

  • 97

    Dissociable substance that accepts hydroxyl ions:

    Acid

  • 98

    Comparing patient’s results with previous results:

    Delta check

  • 99

    is most often performed by nurses, perfusionists (who operate heart-lung machine during open heart surgery), respiratory therapists and physician themselves.

    POCT

  • 100

    Expressed in Ehrlich units (mg/dl):

    Urobilinogen